| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 Jul 2024 | 17 Jul 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve 1) Increase in Authorized Capital of the Company and consequent alteration in Capital Clause of the Memorandum of Association of the Company. 2) To consider & approve the Draft Postal Ballot Notice of the Company and fixing of date of Book closure and e-voting period 3) To appoint Scrutinizer for conducting E- voting process. 4) Any other business with the permission of the Chair 1) increase in Authorized Share Capital of the Company from Rs. 42,00,00,000/- (Rupees Forty Two Crores Only) divided into 42,00,00,000 (Forty Two Crores) Equity Shares of Re. 1/- (Rupee One Only) each to Rs. 60,00,00,000/- (Rupees Sixty Crores Only) divided into 60,00,00,000 (Sixty Crores Only) Equity Shares of Re. 1/- (Rupee One Only) each and consequent Alteration in Capital Clause of the Memorandum of Association of the Company. 2) Approved Draft Postal Ballot Notice pursuant to Section 110 of the Companies Act, 2013 and other applicable provisions 3) appointment of Scrutinizer for conducting Postal Ballot 4) Cut Off date for determining shareholders eligible to vote. (As per BSE Announcement Dated on 20/07/2024) | ||
| Board Meeting | 8 Jul 2024 | 2 Jul 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2024 inter alia to consider and approve Intimation of the Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Board Meeting dated July 08, 2024: 1. Fund Raising through Qualified Institutional Placement (QIP) 2. Allotment of Bonus Shares Kindly take the above on record. (As per BSE Announcement Dated on 08/07/2024) | ||
| Board Meeting | 27 May 2024 | 2 May 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve Audited Financial Results for the quarter and Financial Year ended 31st March 2024 and Consider Recommendation and approval of the issue of Bonus Shares to the existing Equity Shareholders of the Company. The Board Meeting to be held on 10/05/2024 has been revised to 27/05/2024 The Board Meeting to be held on 10/05/2024 has been revised to 27/05/2024 (As per BSE Announcement Dated on 09/05/2024) 1. Financial Results for the quarter and year ended March 31st, 2024 2. issue of Bonus shares (As per BSE Announcement Dated on 27/05/2024) | ||
| Board Meeting | 12 Apr 2024 | 12 Apr 2024 |
| In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, cessation of Dr. Maneesha Naresh, current term of office is completed and she would not be able to continue for another term. Appointment of Internal Auditor and Secretarial Auditor | ||
| Board Meeting | 7 Mar 2024 | 23 Feb 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2024 inter alia to consider and approve Intimation of Board Meeting inter alia to consider acquisition of manufacturing facility near hyderabad producing intermediates for the Pharmaceutical Industry. This is to inform you that the Board of Directors of the Company at its meeting has proposed to acquire a Manufacturing Facility in Hyderabad situated at Phase 2, Survey No.10, Gaddapotharam Industrial Area, Jinnaram Mandal, Medak, Sangareddy District, Hyderabad-502319, Telangana, India. having an area of 130680 square feet. The unit is well equipped to produce Intermediates for the Pharmaceutical Industry. (As Per BSE Announcement dated on 07.03.2024) | ||
| Board Meeting | 14 Feb 2024 | 6 Feb 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Unaudited Financial Results for quarter & nine months ended December 31 2023. Approval of Financial Result on Board Meeting held on Wednesday, February 14, 2024 (As Per BSE Announcement Dated on: 14/02/2024) | ||
| Board Meeting | 8 Jan 2024 | 2 Jan 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/01/2024 inter alia to consider and approve sub-division of shares/ stock split of the company. Outcome for Outcome Of The Board Meeting 1. Sub-division (stock split) of every 1(one) equity share of face value Rs. 5/- each into 5 (five) equity share of face value of Re.1/- 2.Alteration of Capital clause of the Memorandum of Association of the Company consequent upon sub-division/ stock split 3.Appointment of Mr. Adarsh Munjal (DIN: 073040004) Whole-time Director 4. Approval of draft Postal Ballot Notice. 5. Appointment of Scrutinizer. 1. Sub-division (stock split) of every 1(one) equity share of face value Rs. 5/- each into 5 (five) equity share of face value of Re.1/- 2.Alteration of Capital clause of the Memorandum of Association of the Company consequent upon sub-division/ stock split 3.Appointment of Mr. Adarsh Munjal (DIN: 073040004) Whole-time Director 4. Approval of draft Postal Ballot Notice. 5. Appointment of Scrutinizer. (As Per BSE Announcement Dated on 08.01.2024) | ||
| Board Meeting | 11 Nov 2023 | 4 Nov 2023 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th September 2023. Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2023 Unaudited Financial Results for the quarter and half year ending 30.09.2023 (As Per BSE Announcement dated on 11.11.2023) | ||
| Board Meeting | 5 Sep 2023 | 26 Aug 2023 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2023 inter alia to consider and approve Remedium Lifecare Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday September 05 2023 inter alia to transact the following business: 1. To appoint Mr. Adarsh Deepak Munjal (DIN: 07304004) as a Whole Time Director of the Company for a period of 3 years w.e.f. 05.09.2023 subject to the approval of the shareholders at the ensuing Extra Ordinary General Meeting of the company. 2. To consider and take on record the resignation of Dr. Vilas Ramkrishna Lokhande (DIN: 01228041) from the position of Whole Time Director of the Company. 3. Any other matter with the permission of the chair. Outcome of the Board Meeting held on 05.09.2023 (As Per BSE Announcement Dated on 05.09.2023) | ||
| Board Meeting | 12 Aug 2023 | 3 Aug 2023 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the Un-Audited Financial Results for the quarter ended June 30 2023. REMEDIUM LIFECARE LIMITED has informed BSE about Board Meeting to be held on 12 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Outcome of Board Meeting held on Saturday, August 12, 2023. (As per BSE Announcement Dated on 12/08/2023) | ||
| Board Meeting | 31 Jul 2023 | 31 Jul 2023 |
| We wish to inform you that our Company, Remedium Lifecare Limited (the Company) in its Board Meeting held on July 31, 2023 have allotted 64,80,000 Equity Shares of Rs.10/-each as fully paid Bonus Shares to the existing shareholders of the Company as on record date July 29, 2023 in the ratio 9:5 ie. 9 (Nine) fully paid Equity shares for every 5 (Five) Equity shares held. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
